JP2012515540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515540A5 JP2012515540A5 JP2011546813A JP2011546813A JP2012515540A5 JP 2012515540 A5 JP2012515540 A5 JP 2012515540A5 JP 2011546813 A JP2011546813 A JP 2011546813A JP 2011546813 A JP2011546813 A JP 2011546813A JP 2012515540 A5 JP2012515540 A5 JP 2012515540A5
- Authority
- JP
- Japan
- Prior art keywords
- replaced
- region
- nucleic acid
- heavy chain
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200900118 | 2009-01-26 | ||
| DKPA200900118 | 2009-01-26 | ||
| PCT/EP2010/050822 WO2010084197A1 (en) | 2009-01-26 | 2010-01-26 | Methods for producing mixtures of antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016052035A Division JP2016165285A (ja) | 2009-01-26 | 2016-03-16 | 抗体混合物を産生するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012515540A JP2012515540A (ja) | 2012-07-12 |
| JP2012515540A5 true JP2012515540A5 (enExample) | 2013-03-14 |
Family
ID=42060888
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011546813A Ceased JP2012515540A (ja) | 2009-01-26 | 2010-01-26 | 抗体混合物を産生するための方法 |
| JP2016052035A Pending JP2016165285A (ja) | 2009-01-26 | 2016-03-16 | 抗体混合物を産生するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016052035A Pending JP2016165285A (ja) | 2009-01-26 | 2016-03-16 | 抗体混合物を産生するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120020952A1 (enExample) |
| EP (1) | EP2389392A1 (enExample) |
| JP (2) | JP2012515540A (enExample) |
| CN (2) | CN102365296A (enExample) |
| SG (1) | SG172977A1 (enExample) |
| WO (1) | WO2010084197A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1523496T1 (sl) | 2002-07-18 | 2011-11-30 | Merus B V | Rekombinantno proizvajanje zmesi protiteles |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| WO2008027986A2 (en) | 2006-09-01 | 2008-03-06 | Therapeutic Human Polyclonals, Inc. | Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| EP3153524B1 (en) * | 2008-12-03 | 2025-04-23 | Genmab A/S | Antibody variants having modifications in the constant region |
| US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
| CN101983968B (zh) * | 2010-09-26 | 2013-03-06 | 浙江海洋学院 | 乌贼墨寡肽的酶解制备方法 |
| CN103403025B (zh) | 2011-02-28 | 2016-10-12 | 弗·哈夫曼-拉罗切有限公司 | 单价抗原结合蛋白 |
| JP5764677B2 (ja) | 2011-02-28 | 2015-08-19 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 抗原結合タンパク質 |
| JP6031735B2 (ja) * | 2011-06-13 | 2016-11-24 | ソニー株式会社 | 情報処理装置、情報処理方法およびコンピュータプログラム |
| ES2743399T3 (es) | 2012-04-20 | 2020-02-19 | Merus Nv | Métodos y medios para la producción de moléculas heterodiméricas similares a Ig |
| CN102851338A (zh) | 2012-07-25 | 2013-01-02 | 苏州康宁杰瑞生物科技有限公司 | 利用电荷排斥作用制备同二聚体蛋白混合物的方法 |
| US10358492B2 (en) | 2012-09-27 | 2019-07-23 | Merus N.V. | Bispecific IgG antibodies as T cell engagers |
| RU2016115866A (ru) | 2013-10-11 | 2017-11-16 | Ф. Хоффманн-Ля Рош Аг | Мультиспецифические антитела с обменянными доменами и одинаковыми вариабельными доменами легкой цепи |
| TW201609805A (zh) | 2013-12-23 | 2016-03-16 | 美國禮來大藥廠 | 結合ｅｇｆｒ及ｍｅｔ之多功能抗體 |
| SI3110849T1 (sl) | 2014-02-28 | 2021-01-29 | Merus N.V. | Protitelo, ki veže ERBB-2 in ERBB-3 |
| SG11201607109QA (en) | 2014-02-28 | 2016-09-29 | Merus Nv | Antibodies that bind egfr and erbb3 |
| SG11201609207SA (en) * | 2014-05-13 | 2016-12-29 | Univ Pennsylvania | Compositions comprising aav expressing dual antibody constructs and uses thereof |
| CN110658340B (zh) * | 2015-01-08 | 2023-10-31 | 苏州康宁杰瑞生物科技有限公司 | 具有共同轻链的双特异性抗体或抗体混合物 |
| EP3345928B1 (en) | 2015-07-10 | 2020-06-24 | Merus N.V. | Human cd3 binding antibody |
| BR112018008068A2 (en) | 2015-10-23 | 2018-11-13 | Merus N.V. | binding molecules that inhibit cancer growth |
| CA3025162A1 (en) | 2016-05-26 | 2017-11-30 | Qilu Puget Sound Biotherapeutics Corporation | Mixtures of antibodies |
| CA3058343A1 (en) | 2017-03-31 | 2018-10-04 | Merus N.V. | Erbb-2 and erbb-3 binding bispecific antibodies for use in the treatment of cells that have an nrg1 fusion gene |
| US12195551B2 (en) | 2017-05-17 | 2025-01-14 | Merus N.V. | Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer |
| HUE071182T2 (hu) | 2017-08-09 | 2025-08-28 | Merus Nv | EGFR és CMET kötõ antitestek |
| EP4644413A1 (en) | 2024-05-03 | 2025-11-05 | Genmab B.V. | Binding agents having altered fc-mediated effector functions |
| WO2025228542A1 (en) | 2024-05-03 | 2025-11-06 | Genmab B.V. | Method for co-expression of a plurality of antibodies |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003074679A2 (en) * | 2002-03-01 | 2003-09-12 | Xencor | Antibody optimization |
| SI1523496T1 (sl) * | 2002-07-18 | 2011-11-30 | Merus B V | Rekombinantno proizvajanje zmesi protiteles |
| EP1565553A4 (en) * | 2002-10-09 | 2007-11-07 | Integrigen Inc | RECOMBINANT CATALYTIC POLYPEPTIDES AND USES THEREOF |
| EP2395017A3 (en) * | 2003-05-30 | 2012-12-19 | Merus B.V. | Design and use of paired variable regions of specific binding molecules |
| WO2008145137A2 (en) * | 2007-05-31 | 2008-12-04 | Genmab A/S | Recombinant non glycosylated monovalent half-antibodies obtained by molecular engineering |
| PT2235064E (pt) * | 2008-01-07 | 2016-03-01 | Amgen Inc | Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática |
-
2010
- 2010-01-26 CN CN2010800137659A patent/CN102365296A/zh active Pending
- 2010-01-26 WO PCT/EP2010/050822 patent/WO2010084197A1/en not_active Ceased
- 2010-01-26 SG SG2011050903A patent/SG172977A1/en unknown
- 2010-01-26 EP EP10701360A patent/EP2389392A1/en not_active Withdrawn
- 2010-01-26 CN CN201410421605.8A patent/CN104262483A/zh active Pending
- 2010-01-26 US US13/146,297 patent/US20120020952A1/en not_active Abandoned
- 2010-01-26 JP JP2011546813A patent/JP2012515540A/ja not_active Ceased
-
2016
- 2016-03-16 JP JP2016052035A patent/JP2016165285A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012515540A5 (enExample) | ||
| JP7488323B2 (ja) | 抗ｌａｇ－３抗体および組成物 | |
| CN110023335B (zh) | 抗-pd-1抗体、其生产方法及其使用方法 | |
| DK2883449T3 (en) | Histidine engineered light chain antibodies and genetically modified rodents to generate them | |
| JP2021168658A (ja) | Ｉｌ−８に結合する抗体およびその使用 | |
| CA3211407A1 (en) | Anti-gprc5dxbcmaxcd3 trispecific antibody and use thereof | |
| JP2021152040A (ja) | 新規抗ｃｔｌａ４抗体 | |
| JP2016165285A (ja) | 抗体混合物を産生するための方法 | |
| KR20200015756A (ko) | Ig-유사 분자의 제조방법 및 제조수단 | |
| JP2014530001A5 (enExample) | ||
| US20210002362A1 (en) | Il-21 binding proteins and uses thereof | |
| CN117205314A (zh) | 用于癌症治疗的诱导细胞损伤的治疗药物 | |
| JP2022524712A (ja) | 新規の抗ｉｆｎａｒ１抗体 | |
| KR20220064331A (ko) | SARS-CoV-2에 대한 단일 도메인 항체 및 이의 용도 | |
| EP3233120A1 (en) | Il-21 antibodies | |
| KR20240134139A (ko) | 항-갯과 인터루킨-31-수용체 a (il-31ra) 항체 및 이의 용도 | |
| CN116848140A (zh) | 双功能抗pd1/il-7分子 | |
| US20250163182A1 (en) | Enpp3 and cd3 binding agents and methods of use thereof | |
| CN115038497A (zh) | TGF-β-RII结合蛋白质 | |
| TW202307007A (zh) | 多特異性fgf21受體促效劑及其等用途 | |
| WO2025222144A1 (en) | Antibodies and vaccines having vh3-21 and vl1-40 binding domains and uses thereof | |
| CN110573531B (zh) | 经修饰的Cκ和CH1结构域 | |
| KR20240099397A (ko) | 베타 사슬 매개 면역성을 조절하기 위한 조성물 및 방법 | |
| TW202530266A (zh) | 抗ＩＬ－４Ｒα抗體及其用途 | |
| TW202535925A (zh) | 具有增強的Ｆｃ受體結合之Ｆｃ結構域變體 |